Ginkgo Bioworks Holdings, Inc.(DNA)

$6.78—

Chart

Ginkgo Bioworks Holdings, Inc.(DNA)

NYSE

$6.78—

Chart Studio

DNA(DNA)

DNA

Overview Fair Value Stream Notebook Intel Chart History Fundamentals TTM Earnings Analysts News Financials Segments Insiders Institl.DCF Peers

Q4 2026 EPS Estimate

$-0.58

Nov 5, 2026

Revenue Estimate

$21M

Analyst Sentiment

Wall St. Consensus

Hold

11 analysts·Moderate coverage

Score

4 Buy (36%)3 Hold (27%)4 Sell (37%)

Rating Breakdown

Strong Buy

00%

Buy

436%

Hold

327%

Sell

436%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear

$4.35

-35.8%

Consensus

$7.50

+10.6%

Bull

$12.00

+77.0%

12-Month Target Range11 analysts

$4.35$7.50$12.00

Current $6.78Consensus

Current Price

$6.78

Upside to Consensus

$0.72

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev+5.51%

EPS—

FY2028

Rev+240.30%

EPS—

FY2029

Rev+24.53%

EPS—

Raw consensus estimates (low / average / high) from covering analysts.

Annual

Metric	FY2026E	FY2027E	FY2028E	FY2029E
Revenue Avg	$83M	$87M	$296M	$369M
Low	$82M	$87M	$296M	$368M
High	$83M	$87M	$297M	$370M
EBITDA Avg	$-83M	$-87M	$-296M	$-369M
Low	$-83M	$-87M	$-297M	$-370M
High	$-82M	$-87M	$-296M	$-368M
EBIT Avg	$-83M	$-87M	$-296M	$-369M
Low	$-83M	$-87M	$-297M	$-370M
High	$-82M	$-87M	$-296M	$-368M
Net Income Avg	$-194M	$-121M	$-176M	$-124M
Low	$-195M	$-122M	$-177M	$-125M
High	$-194M	$-121M	$-176M	$-124M
EPS Avg	$-3.50	$-2.19	$-3.18	$-2.24
Low	$-3.51	$-2.20	$-3.19	$-2.25
High	$-3.49	$-2.18	$-3.17	$-2.23
Analysts (Rev / EPS)	1 / 1	1 / 1	1 / 1	1 / 1

Quarterly

Metric	Q3 2026	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027
Revenue Avg	$21M	$22M	$22M	$22M	$22M	$22M
Low	$21M	$22M	$21M	$22M	$22M	$22M
High	$21M	$22M	$22M	$22M	$22M	$22M
EBITDA Avg	$-21M	$-22M	$-22M	$-22M	$-22M	$-22M
Low	$-21M	$-22M	$-22M	$-22M	$-22M	$-22M
High	$-21M	$-22M	$-21M	$-22M	$-22M	$-22M
EBIT Avg	$-21M	$-22M	$-22M	$-22M	$-22M	$-22M
Low	$-21M	$-22M	$-22M	$-22M	$-22M	$-22M
High	$-21M	$-22M	$-21M	$-22M	$-22M	$-22M
Net Income Avg	$-72M	$-78M	$-88M	$-74M	$-68M	$-62M
Low	$-72M	$-79M	$-88M	$-74M	$-68M	$-62M
High	$-72M	$-78M	$-87M	$-73M	$-67M	$-62M
EPS Avg	$-1.16	$-1.26	$-1.41	$-1.19	$-1.09	$-1.00
Low	$-1.17	$-1.27	$-1.42	$-1.20	$-1.10	$-1.01
High	$-1.15	$-1.25	$-1.40	$-1.18	$-1.08	$-0.99
Analysts (Rev / EPS)	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1

Earnings Surprises

Recent Analyst Actions

Aug 25, 2025BTIG

Ginkgo Bioworks price target raised to $9 from $6 at BTIG

Target:$9.00

-25.3%from $12.05

Aug 23, 2024BTIG

Ginkgo Bioworks price target lowered to $7 from $8 at BTIG

Target:$7.00

-15.7%from $8.30

Nov 29, 2022Berenberg Bank

Berenberg Initiates Coverage On Ginkgo Bioworks Holdings with Buy Rating, Announces Price Target of $6

Target:$6.00

+226.1%from $1.84

Aug 16, 2022BTIG

BTIG Maintains Buy on Ginkgo Bioworks Holdings, Raises Price Target to $6

Target:$6.00

+60.4%from $3.74

Jun 16, 2022Jefferies

Jefferies Maintains Buy on Ginkgo Bioworks Holdings, Lowers Price Target to $4.35

Target:$4.35

+68.0%from $2.59

Mar 3, 2022Cowen & Co.

Ginkgo Bioworks, Inc. (DNA) Stock: $12 Price Target And Outperform Rating

Target:$12.00

+210.9%from $3.86

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance